QR-Code

Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout

<p>Abstract</p> <p>Background</p> <p>Long term serum urate (SU) lowering to a target of <0.36 mmol/l (6 mg/dl) is recommended for effective gout management. However, many studies have reported low achievement of SU targets. The aim of this cross-sectional study was to examine the clinical and psycho...

Ausführliche Beschreibung

Gespeichert in:
Bibliografische Detailangaben
Hauptverfasser: Dalbeth Nicola, House Meaghan E, Horne Anne, Petrie Keith J, McQueen Fiona M, Taylor William J
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMC 2012-09-01
Schriftenreihe:BMC Musculoskeletal Disorders
Schlagworte:
Online-Zugang:http://www.biomedcentral.com/1471-2474/13/174
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!